<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02364440</url>
  </required_header>
  <id_info>
    <org_study_id>E-1405/250-001</org_study_id>
    <nct_id>NCT02364440</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Evaluation of Ultherapy™ System in Aging Hand</brief_title>
  <official_title>Safety and Efficacy Evaluation of Ultherapy™ System in Aging Hand</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health &amp; Welfare, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Enrolled subjects will receive Ultherapy™ System treatment on the back of their both hands.
      Follow-up visits will occur at 90 days post-treatment. Study photos will be obtained
      pre-treatment and at 90 days post-treatment
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Before Treatment:

      The subject's eligibility (inclusion/exclusion criteria) will be assessed, and the 5-point
      Hand Grading Scale wil be evaluated by the Investigator in charge of assessment.

      Treatment:

      The Investigator will apply to the eligible subject the Study Device Ultherapy™ System with
      20 lines of 1.5 and 3.0 probe respectively to the back of the left and right hand .

      Post-Treatment:

      All subjects will visit the Institution at12 weeks from the day of procedure, and will take
      photos of the back of the hands. Efficacy evaluation will performed by the Photographic
      Evaluator.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Investigator's evaluation of 5-point Hand grading scale</measure>
    <time_frame>12 weeks post-treatment</time_frame>
    <description>2 assessors will be evaluate 5-point Hand grading scale from baseline and 12weeks post treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject Assessment of Improvement at 12 weeks post-treatment</measure>
    <time_frame>12 weeks post-treatment</time_frame>
    <description>Subjects complete a Patient Assessment Global Aesthetic Improvement Scale at 12 weeks post-treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator Assessment of Improvement at 12 weeks post-treatment</measure>
    <time_frame>12 weeks post-treatment</time_frame>
    <description>Investigator complete Global Aesthetic Improvement Scale at 12 weeks post-treatment by comparing subject's photographs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects' Assessment of Pain during treatment</measure>
    <time_frame>Subjects were assessed for the duration of study treatment</time_frame>
    <description>Pain score record using a Numeric Rating Scale (NRS,0-10) , with 0 representing no pain and 10 representing the worst pain possible.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Wrinkles</condition>
  <arm_group>
    <arm_group_label>Ultherapy™ System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultherapy™ System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultherapy™ System</intervention_name>
    <description>Subjects will receive 20 lines Ultherapy™ System Treatment over their right and left hand with 1.5 and 3.0 probe respectively</description>
    <arm_group_label>Ultherapy™ System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, aged 30 to 65 years.

          -  Score of 1 to 3 on The 5-point Hand Grading Scale

          -  Subjects who understand the study contents and signed the informed consent

        Exclusion Criteria:

          -  Presence of an active systemic infectious disease

          -  Significant scarring in the hand to be treated

          -  Previous episode of surgery in the hand to be treated

          -  Subjects who have aesthetic addiction, drug abuse, alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ChangSik Pak, Bachelor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2015</study_first_submitted>
  <study_first_submitted_qc>February 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2015</study_first_posted>
  <last_update_submitted>May 7, 2015</last_update_submitted>
  <last_update_submitted_qc>May 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>skin laxity</keyword>
  <keyword>Ultherapy™ System</keyword>
  <keyword>rhytids</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

